Literature DB >> 16626304

Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13.

Mike P Williamson1, Yu Suzuki, Nathan T Bourne, Tetsuo Asakura.   

Abstract

Amyloid beta-peptide (Abeta) is a major component of plaques in Alzheimer's disease, and formation of senile plaques has been suggested to originate from regions of neuronal membrane rich in gangliosides. Here we demonstrate using NMR on 15N-labelled Abeta-(1-40) and Abeta-(1-42) that the interaction with ganglioside G(M1) micelles is localized to the N-terminal region of the peptide, particularly residues His13 to Leu17, which become more helical when bound. The key interaction is with His13, which undergoes a G(M1)-specific conformational change. The sialic acid residue of the ganglioside headgroup is important for determining the nature of the conformational change. The isolated pentasaccharide headgroup of G(M1) is not bound, suggesting the need for a polyanionic surface. Binding to heparin confirms this suggestion, since binding is of similar affinity but does not produce the same conformational changes in the peptide. A comparison of Abeta-(1-40) and Abeta-(1-42) indicates that binding to G(M1) micelles is not related to oligomerization, which occurs at the C-terminal end. These results imply that binding to ganglioside micelles causes a transition from random coil to alpha-helix in the N-terminal region, leaving the C-terminal region unstructured.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626304      PMCID: PMC1533309          DOI: 10.1042/BJ20060293

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Solution structure and DNA binding of the effector domain from the global regulator PrrA (RegA) from Rhodobacter sphaeroides: insights into DNA binding specificity.

Authors:  Cédric Laguri; Mary K Phillips-Jones; Michael P Williamson
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

2.  Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes.

Authors:  Atsuko Kakio; Sei-ichi Nishimoto; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  Biochem Biophys Res Commun       Date:  2003-04-04       Impact factor: 3.575

3.  Probing multiple effects on 15N, 13C alpha, 13C beta, and 13C' chemical shifts in peptides using density functional theory.

Authors:  Xiao-Ping Xu; David A Case
Journal:  Biopolymers       Date:  2002-12-15       Impact factor: 2.505

4.  Characterization of high-affinity binding between gangliosides and amyloid beta-protein.

Authors:  T Ariga; K Kobayashi; A Hasegawa; M Kiso; H Ishida; T Miyatake
Journal:  Arch Biochem Biophys       Date:  2001-04-15       Impact factor: 4.013

5.  Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.

Authors:  Atsuko Kakio; Sei-ichi Nishimoto; Katsuhiko Yanagisawa; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

6.  Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid.

Authors:  A Kakio; S I Nishimoto; K Yanagisawa; Y Kozutsumi; K Matsuzaki
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

7.  Polyphenol/peptide binding and precipitation.

Authors:  Adrian J Charlton; Nicola J Baxter; M Lokman Khan; Arthur J G Moir; Edwin Haslam; Alan P Davies; Michael P Williamson
Journal:  J Agric Food Chem       Date:  2002-03-13       Impact factor: 5.279

8.  Solution NMR study of the interaction between NTF2 and nucleoporin FxFG repeats.

Authors:  Jonathan Morrison; Ji-Chun Yang; Murray Stewart; David Neuhaus
Journal:  J Mol Biol       Date:  2003-10-24       Impact factor: 5.469

9.  Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.

Authors:  Marcus Bokvist; Fredrick Lindström; Anthony Watts; Gerhard Gröbner
Journal:  J Mol Biol       Date:  2004-01-23       Impact factor: 5.469

Review 10.  Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

Authors:  D M Walsh; I Klyubin; J V Fadeeva; M J Rowan; D J Selkoe
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

View more
  38 in total

Review 1.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

Review 2.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

3.  Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation.

Authors:  Christina Dammers; Kerstin Reiss; Lothar Gremer; Justin Lecher; Tamar Ziehm; Matthias Stoldt; Melanie Schwarten; Dieter Willbold
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

4.  Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.

Authors:  Hovig Kouyoumdjian; David C Zhu; Mohammad H El-Dakdouki; Kelly Lorenz; Jianjun Chen; Wei Li; Xuefei Huang
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

5.  Total Synthesis of the Aminopropyl Functionalized Ganglioside GM(1).

Authors:  Bin Sun; Bo Yang; Xuefei Huang
Journal:  Sci China Chem       Date:  2012-01-01       Impact factor: 9.445

6.  Measuring translational diffusion coefficients of peptides and proteins by PFG-NMR using band-selective RF pulses.

Authors:  Shenggen Yao; Daniel K Weber; Frances Separovic; David W Keizer
Journal:  Eur Biophys J       Date:  2014-05-14       Impact factor: 1.733

7.  NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.

Authors:  Yiling Xiao; Isamu Matsuda; Masafumi Inoue; Tomoya Sasahara; Minako Hoshi; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2019-11-26       Impact factor: 5.157

Review 8.  Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.

Authors:  Samuel A Kotler; Patrick Walsh; Jeffrey R Brender; Ayyalusamy Ramamoorthy
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

9.  Up-and-down topological mode of amyloid beta-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters.

Authors:  Maho Utsumi; Yoshiki Yamaguchi; Hiroaki Sasakawa; Naoki Yamamoto; Katsuhiko Yanagisawa; Koichi Kato
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

10.  The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?

Authors:  Kerensa Broersen; Frederic Rousseau; Joost Schymkowitz
Journal:  Alzheimers Res Ther       Date:  2010-07-14       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.